Paul Lammers

Company: Triumvira Immunologics

Job title: Chief Executive Officer

Seminars:

Natural Activation of T-Cells Through the TAC Receptor Provides Ideal Characteristics for Adoptive Cell Therapy 1:00 pm

Unique structure and biology of TAC T-cells Deep penetration and activation of TAC T-cells into solid tumors Update on TAC01-HER2 Phase I/II clinical trial in patients with HER2-overexpressing solid tumorsRead more

day: Conference Day Two